Menu

Using UNC's expertise to fight emerging diseases


Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related:

Beyond Boo-Yah: How Stuart Scott’s friends carry his memory to this day
What comes to mind when you hear the name Stuart Scott? For Roy Williams, it’s as simple as a smile. "That’s the best thing...that’s a...

Filmmaker Andre Gaines on ‘the honor’ of making a Stuart Scott 30 for 30
In ESPN’s history, few SportsCenter anchors have become cultural icons. UNC alumnus Stuart Scott persevered to become one of The Worldwide Leader in Sports’ most...

Stuart Scott 30 for 30 showcases ESPN legend who changed the game
Stuart Scott is the subject of ESPN’s latest 30 for 30 film: “Boo-Yah: A Portrait of Stuart Scott,” which premieres on Dec. 10 at 9...

Giving tours of Carolina strengthened Gillian Kepley’s love for it
If there was a record book for most campus tours given by a Carolina student, Gillian Kepley ’25 would probably find her name at the...